imho most of the screening programs will be government directed and driven. the estimates for costs / deaths of colorectal cancer treatment - for Aus alone comes in at just over $8.5 billion (say 17 yr period) not including loss of life intangibles. I query whether marketing spend will be in issue. for example the cervical cancer screening program simply tells the GP's what process to use (recently changed from Pap smear program to a DNA cytology based program) this has no marketing it was simply government directive because it was superior. I anticipate agreements with govt as national screening program partners as opposed to driven by marketing spend
- Forums
- ASX - By Stock
- Ann: CE Mark Granted for ColoSTAT
imho most of the screening programs will be government directed...
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.68M |
Open | High | Low | Value | Volume |
4.7¢ | 4.8¢ | 4.2¢ | $9.183K | 197.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51425 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 68500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 51425 | 0.047 |
2 | 52542 | 0.043 |
1 | 47470 | 0.042 |
2 | 140586 | 0.041 |
2 | 524995 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 68500 | 1 |
0.056 | 20000 | 1 |
0.065 | 19644 | 2 |
0.066 | 79998 | 1 |
0.070 | 340394 | 2 |
Last trade - 14.17pm 02/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |